
CRH Medical Corporation CRHM
Land |
|
IPO-Jahr |
2015 |
Branche |
Medizinische Instrumente |
Börse |
NYSE AMERICAN |
Anteile |
71.5 M |
Marktkapitalisierung |
$ 282 M |
EBITDA (LTM) |
$ -6.25 M |
P/E (LTM) |
- |
P/S (LTM) |
- |
EPS (LTM) |
- |
Andere Aktien der Branche "Medizinische Instrumente"
| Name | Preis | % 24h | Marktkapitalisierung | Börse | Land | |
|---|---|---|---|---|---|---|
|
Masimo Corporation
MASI
|
$ 178.66 | 0.12 % | $ 9.52 B | Nasdaq Global Select Market,SPB | ||
|
ICU Medical
ICUI
|
$ 129.49 | -0.34 % | $ 3.19 B | Nasdaq Global Select Market,SPB | ||
|
Luminex Corporation
LMNX
|
- | - | $ 1.75 B | Nasdaq Global Select Market | ||
|
Merit Medical Systems
MMSI
|
$ 67.56 | -0.84 % | $ 4 B | Nasdaq Global Select Market,SPB | ||
|
Akers Biosciences, Inc.
AKER
|
- | -9.52 % | $ 20.6 M | Nasdaq Capital Market | ||
|
Atrion Corporation
ATRI
|
- | - | $ 810 M | Nasdaq Global Select Market,SPB | ||
|
Ekso Bionics Holdings
EKSO
|
$ 10.75 | 1.42 % | $ 26.1 M | Nasdaq Capital Market | ||
|
Antares Pharma, Inc.
ATRS
|
- | - | $ 955 M | Nasdaq Capital Market | ||
|
Cantel Medical Corp.
CMD
|
- | -1.18 % | $ 3.4 B | NYSE | ||
|
Envista Holdings Corporation
NVST
|
$ 26.07 | 0.93 % | $ 4.38 B | NYSE | ||
|
Hill-Rom Holdings, Inc.
HRC
|
- | -0.05 % | $ 10.3 B | NYSE,SPB | ||
|
Varian Medical Systems, Inc.
VAR
|
- | -0.02 % | $ 16.3 B | NYSE | ||
|
Nephros
NEPH
|
$ 3.06 | -1.61 % | $ 31.8 M | Nasdaq Global Select Market | ||
|
Haemonetics Corporation
HAE
|
$ 56.93 | -2.63 % | $ 2.87 B | NYSE,SPB | ||
|
Pro-Dex
PDEX
|
$ 50.14 | 4.56 % | $ 165 M | Nasdaq Global Select Market | ||
|
Baxter International
BAX
|
$ 16.79 | 0.96 % | $ 8.61 B | NYSE,SPB | ||
|
Pulse Biosciences
PLSE
|
$ 21.62 | 3.27 % | $ 1.46 B | Nasdaq Global Select Market | ||
|
OraSure Technologies
OSUR
|
$ 3.07 | -0.49 % | $ 226 M | Nasdaq Global Select Market,SPB | ||
|
Isoray
ISR
|
- | 0.03 % | $ 108 M | NYSE American | ||
|
AngioDynamics
ANGO
|
$ 10.66 | -0.47 % | $ 435 M | Nasdaq Global Select Market | ||
|
Intuitive Surgical
ISRG
|
$ 475.35 | -0.56 % | $ 170 B | Nasdaq Global Select Market,SPB | ||
|
AtriCure
ATRC
|
$ 29.69 | -0.3 % | $ 1.42 B | Nasdaq Global Market,SPB | ||
|
InfuSystem Holdings
INFU
|
$ 9.67 | 0.73 % | $ 200 M | NYSE American | ||
|
Repligen Corporation
RGEN
|
$ 116.8 | 0.39 % | $ 6.51 M | Nasdaq Global Select Market,SPB | ||
|
iRhythm Technologies
IRTC
|
$ 118.91 | 0.65 % | $ 3.81 B | Nasdaq Global Select Market,SPB | ||
|
BioLife Solutions
BLFS
|
$ 19.71 | 2.82 % | $ 908 M | Nasdaq Global Select Market | ||
|
Milestone Scientific
MLSS
|
$ 0.3 | 4.7 % | $ 23.9 M | NYSE American | ||
|
electroCore
ECOR
|
$ 6.19 | 0.98 % | $ 52.5 K | Nasdaq Global Select Market | ||
|
STERIS plc
STE
|
$ 223.11 | 0.93 % | $ 22 B | NYSE,SPB | ||
|
Stereotaxis
STXS
|
$ 1.82 | -1.36 % | $ 166 M | NYSE American | ||
|
Teleflex Incorporated
TFX
|
$ 107.61 | 1.55 % | $ 4.8 B | NYSE,SPB | ||
|
Predictive Oncology
POAI
|
- | - | $ 31.1 M | Nasdaq Capital Market | ||
|
Glaukos Corporation
GKOS
|
$ 105.56 | -1.19 % | $ 5.11 B | NYSE,SPB | ||
|
Utah Medical Products
UTMD
|
$ 64.33 | -1.22 % | $ 233 M | Nasdaq Global Select Market | ||
|
ResMed
RMD
|
$ 229.74 | 0.75 % | $ 33.6 B | NYSE,SPB | ||
|
Microbot Medical
MBOT
|
$ 2.51 | -0.6 % | $ 25.6 M | Nasdaq Global Select Market | ||
|
Retractable Technologies
RVP
|
$ 0.72 | 0.68 % | $ 21.6 M | NYSE American | ||
|
West Pharmaceutical Services
WST
|
$ 246.11 | 1.87 % | $ 17.8 B | NYSE,SPB | ||
|
DENTSPLY SIRONA
XRAY
|
$ 11.59 | 0.39 % | $ 2.31 B | Nasdaq Global Select Market,SPB | ||
|
NeuroMetrix
NURO
|
- | 5.05 % | $ 9.02 M | Nasdaq Global Select Market | ||
|
The Cooper Companies
COO
|
$ 70.97 | 1.05 % | $ 14.1 B | NYSE,SPB | ||
|
STAAR Surgical Company
STAA
|
$ 19.11 | 3.24 % | $ 947 M | Nasdaq Global Market,SPB | ||
|
Harvard Bioscience
HBIO
|
$ 5.15 | -3.58 % | $ 229 M | Nasdaq Global Market | ||
|
Becton, Dickinson and Company
BDX
|
$ 155.62 | -0.38 % | $ 44.8 B | NYSE,SPB | ||
|
LeMaitre Vascular
LMAT
|
$ 110.44 | 2.39 % | $ 2.5 B | Nasdaq Global Market,SPB | ||
|
Repro Med Systems
KRMD
|
$ 4.44 | 0.23 % | $ 205 M | Nasdaq Capital Market | ||
|
Alcon
ALC
|
$ 74.45 | 0.45 % | $ 40.4 B | NYSE |